Skip to main content

Table 1 Participant Characteristics with Measures of Central Tendencies at Baseline, 12-month and 11-year follow-up for age, BMI and the number of co-morbidities. Between group differences evaluated with between the Median (IQR) via the Independent-samples Mann-Whitney U Testa

From: The natural history of greater trochanteric pain syndrome: an 11-year follow-up study

Characteristic

Baseline

12-month follow-up

11-year follow-up

Groups

Difference between groups

Groups

Difference between groups

Groups

Difference between groups

GTPS (n = 31)

ASC (n = 23)

GTPS minus ASC

Mann-Whitney U Test

GTPS (n = 31)

ASC (n = 21)

GTPS minus ASC

Mann-Whitney U Test

GTPS (n = 24)

ASC (n = 20)

GTPS minus ASC

Mann-Whitney U Test

Age (yr)

56.0 (43.0-62.0)

49.0 (43.0-61.0)

7.0

p = 0.706

57.0 (44.0-63.0)

58.0 (44.0-62.5)

-1.0

p = 0.911

62.0 (52.5-72.0)

63.0 (53.3-72.0)

-1.0

p = 0.878

BMI (kg/m2)

27.3

(24.7 to 30.7)

24.2

(22.8 to 27.7)

3.1

p=0.035*

27.3

(24.4 to 29.4)

24.1

(22.5 to 26.8)

3.2

p=0.031*

25.9

(24.5 to 29.9)

25.4

(22.5 to 29.4)

0.5

p = 0.572

Comorbidities (FCI - number)

3 (1.0-4.0)

1 (0.0-2.0)

2

p=0.006*

2 (1.0 to 4.0)

1 (1.0 to 1.5)

1

p=0.007*

2 (1.0-3.8)

2 (1.0-2.0)

0

p=0.175

  1. Note: GTPS Greater Trochanteric Pain Syndrome, ASC Asymptomatic Control Group, yr year, FCI Functional Co-morbidity Index, BMI Body Mass Index, IQR Interquartile range, *Statistically significant (p < 0.05).
  2. aBaseline and 12-month data does not include those excluded from 11-year follow-up, but does include those lost to follow-up